Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,236 public trials 880 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Recruiting

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

NCT07549412

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Rocky Mountain Cancer Centers, LLP- Aurora Lone Tree, Colorado, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
  • Illinois CancerCare PC Peoria, Illinois, United States
  • Springfield Clinic Springfield, Illinois, United States
View all 21 locations
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

NCT06974110

Conditions
Advanced Solid Tumor, Colonic Diseases, Colorectal Cancer, +31 more
Locations
  • Investigative Site #132 Phoenix, Arizona, United States
  • Investigative Site #101 San Diego, California, United States
  • Investigative Site #128 Tampa, Florida, United States
  • Investigative Site #120 Detroit, Michigan, United States
View all 15 locations
View Trial Details
Recruiting

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

NCT07147231

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

TheraSphere Japan Pre-Market Study

NCT07377487

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations
  • Hyogo College of Medicine Hospital Nishinomiya, Hyōgo, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
  • National Cancer Center Hospital Chuo Ku, Tokyo, Japan
View Trial Details
Recruiting

PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

NCT07133750

Conditions
CRC (Colorectal Cancer), Colonic Diseases, Colorectal Neoplasms, +9 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
View Trial Details

Related conditions